Forbion Capital Partners Management Holding BV

Forbion Capital Partners Management Holding BV

Forbion Capital Partners Management Holding BV

Overview
Date Founded

2007

Headquarters

Gooimeer 2-35,Naarden, Noord-Holland 1411 DC

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Private Equity & Venture Capital
Hospitals & Patient Services
Biotechnology
Investment Services & Portfolio Management

Company Description

Forbion is an active manager which invests in life sciences and biomedical technology companies in Northwest Europe and the US. The firm focuses on companies that have innovative technologies and drug development programs. In Europe, Forbion tends to take the lead investor role, while in the US they prefer to be a co-lead investor, making initial investments ranging from EUR 1 - EUR 7 million, and participates in follow-on investments. Forbion generally takes a seat on the board of directors.

Contact Data
Trying to get in touch with decision makers at Forbion Capital Partners Management Holding BV? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Co-Founder

Managing Partner

General Partner

General Partner

General Partner

Venture Partner

Partner

Partner

Venture Partner

Paths to Forbion Capital Partners Management Holding BV
Potential Connections via
Relationship Science
You
Forbion Capital Partners Management Holding BV
Recent Transactions
Details Hidden

Roche Holding AG purchases Promedior, Inc. from HealthCare Ventures LLC, Polaris Partners, Easton Capital Investment Group, Forbion Capital Partners Management Holding BV, Morgenthaler Management Corp., BioMed Ventures

Details Hidden

Edwards Lifesciences Corp. purchases Mitralign, Inc. from Oxford Bioscience Partners, Giza Venture Capital, Orchestra Medical Ventures LLC, Triathlon Medical Venture Partners LLC, Forbion Capital Partners Management Holding BV, Palisade Capital Management (Private Equity)

Details Hidden

Bio-Techne Corp. purchases Exosome Diagnostics, Inc. from NGN Capital LLC, Forbion Capital Partners Management Holding BV, Julip Run Capital LLC, btov Partners AG

Transaction Advisors
Legal Advisor

Advised onAmgen, Inc. purchases BioVex Group, Inc. from Scottish Equity Partners LLP, Kreos Capital Management (UK) Ltd., Lloyds Development Capital (Holdings) Ltd., MVM Partners LLP, Ventech SA, Beringea LLP, IPSA SAS, Avalon Ventures Management LLC, GeneChem Management, Inc., New Science Ventures LLC, Morningside Group Ltd., Triathlon Medical Venture Partners LLC, 180 Degree Capital, Omnes Capital SAS /Venture, Forbion Capital Partners Management Holding BV, Ysios Capital Partners SGEIC SA, Sectoral Asset Management Inc (Private Equity)

Legal Advisor

Advised onAmgen, Inc. purchases Dezima Pharma BV from New Science Ventures LLC, Forbion Capital Partners Management Holding BV, Biogeneration Management BV

Escrow Agent

Advised onBio-Techne Corp. purchases Exosome Diagnostics, Inc. from NGN Capital LLC, Forbion Capital Partners Management Holding BV, Julip Run Capital LLC, btov Partners AG

Investments
Details Hidden

Gotham Therapeutics Corp. develops and manufactures pharmaceutical medicines. The firm develops new treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases. The company was founded by Samie Jaffrey in 2017 and is headquartered in New York, NY.

Details Hidden

Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.

Details Hidden

CatalYm GmbH specializes in catalyzing immunotherapy. The company is headquartered in Munich, Germany.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Forbion Capital Partners Management Holding BV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Forbion Capital Partners Management Holding BV's profile does not indicate a business or promotional relationship of any kind between RelSci and Forbion Capital Partners Management Holding BV.